6 - What's Hot in ID + HIV

Wednesday, October 19, 2022

1:30 PM – 3:15 PM US ET

Location: Ballroom ABC (3rd Floor)

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Adarsh Bhimraj, MD

Director, Infectious Diseases Fellowship and Education
Division of Infectious Diseases, Houston Methodist Hospital
Houston Methodist Hospital
Houston, TX, United States

Disclosure(s): No financial relationships to disclose
Harry Lampiris, MD

Chief, Infectious Disease Section, Medical Service
San Francisco VA Medical Center/UCSF
San Francisco, CA, United States

Disclosure(s): No financial relationships to disclose

Faculty(s)

Katharine Bar, MD

Assistant Professor of Medicine
University of Pennsylvania
Phildelphia, PA, United States

Disclosure(s): Abbvie: Advisor/Consultant (Ongoing)

Slides
Marwan Haddad, MD, MPH, AAHIVS

Medical Director, Center for Key Populations
Community Health Center Inc.
Middletown, CT, United States

Disclosure(s): Yale University: Advisor/Consultant (Ongoing), Honoraria (Ongoing)

Slides
Preeti Malani, MD, MSJ

Professor of Medicine
University of Michigan
Ann Arbor, MI, United States

Disclosure(s): No financial relationships to disclose

Slides
David Relman, MD

Thomas C. and Joan M. Professor
Stanford University
Palo Alto, CA, United States

Disclosure(s): Blue Willow Biologics: Stocks/Bonds (Ongoing); Cantata Bio: Board Member (Ongoing), Stocks/Bonds (Ongoing); Evelo Biosciences: Stocks/Bonds (Ongoing); Karius: Stocks/Bonds (Ongoing); ProdermIQ: Stocks/Bonds (Ongoing); Second Genome: Stocks/Bonds (Ongoing); Visby Medical: Board Member (Ongoing)

Slides

Disclosure(s):

Adarsh Bhimraj, MD: No financial relationships to disclose

Harry Lampiris, MD: No financial relationships to disclose

Katharine Bar, MD: Abbvie: Advisor/Consultant (Ongoing)

Marwan Haddad, MD, MPH, AAHIVS: Yale University: Advisor/Consultant (Ongoing), Honoraria (Ongoing)

Preeti Malani, MD, MSJ: No financial relationships to disclose

David A. Relman, MD: Blue Willow Biologics: Stocks/Bonds (Ongoing); Cantata Bio: Board Member (Ongoing), Stocks/Bonds (Ongoing); Evelo Biosciences: Stocks/Bonds (Ongoing); Karius: Stocks/Bonds (Ongoing); ProdermIQ: Stocks/Bonds (Ongoing); Second Genome: Stocks/Bonds (Ongoing); Visby Medical: Board Member (Ongoing)

CME Credits: Maximum of 1.75 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.75 hours of MOC Credit
CNE Credits: Maximum of 1.75 hours of ANCC Credit
ACPE Credits: ACPE 1.75 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

discuss new treatment options available for people living with HIV or at risk for HIV infection;
describe new developments in HIV pathogenesis and cure research;
describe the current status of HIV eradication initiatives in U.S. and globally

Presentations:

1:30 PM – 1:55 PM US ET

What's Hot: HIV Basic Science
Speaker: Katharine Bar, MD – University of Pennsylvania
1:55 PM – 2:20 PM US ET

What's Hot: HIV Clinical Science
Speaker: Marwan Haddad, MD, MPH, AAHIVS – Community Health Center Inc.
2:20 PM – 2:45 PM US ET

What's Hot: ID Basic Science
Speaker: David A. Relman, MD – Stanford University
2:45 PM – 3:10 PM US ET

What's Hot: ID Clinical Science
Speaker: Preeti Malani, MD, MSJ – University of Michigan